This fake-drug explosion could be a real threat to consumer safety. Patients need to take the FDA and WHO warnings seriously.
Merrill Matthews is a Resident Scholar at the Institute for Policy Innovation and holds a Ph.D. from the University of Texas, Dallas. He is a contributor to various publications, including The Hill and RealClearHealth, and has also been featured in The Wall Street Journal, The Dallas Morning News, and other outlets. His articles cover a range of topics, including politics, healthcare, economics, and public policy.